article thumbnail

Patent, Trademark, and Copyright: Definitions and Distinctions

Erik K Pelton

The following is an edited transcript of my video Patent, Trademark, and Copyright Definitions and Differences. The following is an edited transcript of my video Patent, Trademark, and Copyright Definitions and Differences. A patent registration generally lasts for 20 years from the time the application was filed.

Trademark 130
article thumbnail

[GuestPost] How the European Patent Office uses AI to facilitate patent searches

The IPKat

In a second of a series on AI and patents from our KatFriends at GJE, Kate Voller reports on a recent CIPA webinar with the EPO on how the EPO is leveraging AI tools in examination - with the key message of "assisting", not "replacing" examiners. The AmeriKat has the t-shirt.now what?

Patent 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Substance of OpenAI’s Patent Pledge?

Patently-O

by Dennis Crouch OpenAI’s new patent pledge promises to use their patents only for defensive purposes, as long as other parties do not assert claims against them or engage in harmful activities. See Jorge Contreras, Patent Pledges , 47 Ariz. Continue reading this post on Patently-O.

Patent 122
article thumbnail

Patent Claim Count

Patently-O

The updated patent claim count data through 2024 reveals a continuing trend toward standardization in claim counts, with both the median and mean hovering around 16-17 claims per patent. Read more here: Central Tendency in US Patent Claim Counts Continue reading this post on Patently-O.

Patent 111
article thumbnail

IPO Diversity in Innovation Toolkit

Women and diverse employees have the technical skill and knowledge, yet their contributions are not patented at the same rate as those of their male counterparts.This toolkit can help organizations move the needle on achieving gender parity in innovation.

article thumbnail

Debunked: USPTO Findings Should End False Pharma Patent Narratives

IP Watchdog

Patent and Trademark Office (USPTO), whose “Drug Patent and Exclusivity Study” effectively debunks the false narratives and bogus statistics that have been levied against pharmaceutical patents with significant effect in recent years. One of the more interesting public policy reads of 2024 comes from the U.S.

Patent 119
article thumbnail

USPTO Patent Grant Rate and Growing Backlog

Patently-O

by Dennis Crouch The USPTO utility patent grant rate data reveals an interesting narrative of policy shifts and administrative changes over the past fifteen years. Continue reading this post on Patently-O.

Patent 115